ABVC BioPharma, Inc. (ABVC)
1.04
-0.05
(-4.59%)
USD |
NASDAQ |
Oct 29, 16:00
1.05
+0.01
(+0.96%)
Pre-Market: 20:00
ABVC BioPharma Price to Book Value : 2.605 for Oct. 29, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 2.605 |
| October 28, 2026 | 2.730 |
| October 27, 2026 | 2.630 |
| October 26, 2026 | 2.630 |
| October 23, 2026 | 2.605 |
| October 22, 2026 | 2.623 |
| October 21, 2026 | 2.505 |
| October 20, 2026 | 2.330 |
| October 19, 2026 | 2.279 |
| October 16, 2026 | 2.299 |
| October 15, 2026 | 2.336 |
| October 14, 2026 | 2.555 |
| October 13, 2026 | 2.452 |
| October 12, 2026 | 2.454 |
| October 09, 2026 | 2.505 |
| October 08, 2026 | 2.455 |
| October 07, 2026 | 2.505 |
| October 06, 2026 | 2.430 |
| October 05, 2026 | 2.455 |
| October 02, 2026 | 2.530 |
| October 01, 2026 | 2.555 |
| September 30, 2026 | 2.655 |
| September 29, 2026 | 2.605 |
| September 28, 2026 | 2.630 |
| September 25, 2026 | 2.830 |
| Date | Value |
|---|---|
| September 24, 2026 | 2.730 |
| September 23, 2026 | 2.856 |
| September 22, 2026 | 2.906 |
| September 21, 2026 | 2.881 |
| September 18, 2026 | 2.906 |
| September 17, 2026 | 2.881 |
| September 16, 2026 | 2.705 |
| September 15, 2026 | 2.680 |
| September 14, 2026 | 2.505 |
| September 11, 2026 | 2.455 |
| September 10, 2026 | 2.445 |
| September 09, 2026 | 2.430 |
| September 08, 2026 | 2.655 |
| September 04, 2026 | 2.405 |
| September 03, 2026 | 2.505 |
| September 02, 2026 | 2.165 |
| September 01, 2026 | 2.068 |
| August 31, 2026 | 2.148 |
| August 28, 2026 | 2.079 |
| August 27, 2026 | 1.993 |
| August 26, 2026 | 1.781 |
| August 25, 2026 | 2.004 |
| August 24, 2026 | 2.104 |
| August 21, 2026 | 2.250 |
| August 20, 2026 | 2.250 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 2.124 |
| Perspective Therapeutics, Inc. | 0.4122 |
| MiMedx Group, Inc. | 2.745 |
| Abbott Laboratories | 3.540 |
| AngioDynamics, Inc. | 3.196 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0842 |
| Price | 1.04 |
| Earnings Yield | -27.67% |
| Market Cap | 26.80M |
| PEGY Ratio | -0.0842 |